Pairwise comparisons indicated that the mean tumor size for the KRAS mutation-positive group was significantly larger than that of the ALK mutation-positive group (p = 0.01), which was significantly larger than that of the EGFR mutation-positive group (p = 0.001). The gene discussed is KRAS; the disease is neoplasm.